Influence of Tumor Characteristics and Time to Metastatic Disease on Oncological Outcomes in Metachronous Metastatic Prostate Cancer Patients.
Mike WenzelMalin LutzBenedikt HoehFlorestan KollCristina Cano GarciaCarolin SiechThomas SteuberMarkus GraefenDerya TilkiLuis A KluthSéverine BanekFelix K H ChunPhilipp MandelPublished in: Clinical genitourinary cancer (2024)
Timing of mmPCa is strongly influenced by grading and pT-stage in real-life setting. OS benefits can be observed with longer time interval between primary PCa diagnosis and onset of mmPCa.